Skip to content

Randomized controlled study evaluating the effectiveness of a 3-week Schrothkur compared to a 3-week holiday stay in Oberstaufen specifically tailored to people suffering from type 2 diabetes mellitus

Randomized controlled study evaluating the effectiveness of a 3-week Schrothkur compared to a 3-week holiday stay in Oberstaufen specifically tailored to people suffering from type 2 diabetes mellitus - -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010714
Enrollment
100
Registered
2016-06-22
Start date
2014-09-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11.90

Interventions

Group 1: 1. Schrothkur: 3-week Schrothkur with four therapeutic elements (1) Schroth’s Diet (therapeutic fasting: light food, calorie-reduced, mainly basic, fat- and animal protein-free, almost salt
Kur drinks are herbal tea, mineral water, fruit juices, and, only by doctor's prescription, small amounts of dry wine), (4) daily change in higher body activities and rest days (drinking days are days
dry days are rest days (relaxation exercises, massages, walks, resting, reading etc.)
participation in the following events (obligatory): introductory talk by spa physician (1 hour)
nutrition lecture (2 hours)
"Gentle hiking" with a climate therapist (8 times
2 hours)
exchange of experience in the group moderated by a diabetes counselor twice a week (1.5 hours each)
each participant will receive a pedometer for checking his/her daily exercise habits and to create an incentive for additional physical activity
a further optional activity includes personal meetings with the diabetes counselor Group 2: 2. Holiday stay directed specially at diabetics: 3-week holiday stay specifically tailored to people suffe

Sponsors

Lehrstuhl für Public Health und Versorgungsforschung am IBE,Fachbereich Medizinische Klimatologie, Kurortmedizin und Prävention, LMU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: type 2 diabetes mellitus (medically confirmed diagnosis); HbA1c = 6,5% (48 mmol/mol); BMI = 27; participants were informed about the content and purpose of the study and gave their written informed consent

Exclusion criteria

Exclusion criteria: type 1 diabetes mellitus; severe diabetic complications (e.g. diabetic foot, kidney failure, and diabetic retinopathy); malignant tumor in the last 12 months; acute infection; liver cirrhosis; heart failure (NYHA III and IV); kidney failure (creatinine > 1,5mg%); pregnancy; mental illness (e.g. depression, psychosis)

Design outcomes

Primary

MeasureTime frame
long-term glucose parameter HbA1c in conjunction with taking diabetes-related medicines at 6 months (antidiabetics, insulin) – pre, 2 weeks, post, 3, 6 months

Secondary

MeasureTime frame
pre, 2 weeks, post, 3, 6 months: Body Mass Index (BMI); blood pressure; diabetes-related blood tests (fructosamine, CRP, HDL cholesterol, LDL cholesterol, triglycerides, creatinine, uric acid, TSH, GOT, GPT, GGT); well-being (World Health Organization 5-item Well-Being Index – WHO-5); general health / quality of life (EuroQol (EQ-5D-5L general health index); pre, post: analysis of VNS/HRV; pre, post, 6 months: blood tests (C-peptide, proinsulin); pre, 3, 6 months: general health / health-related quality of life (SF-36); health-related behavior; pre, 6 months: days of sick leave (last 6 months); during the 3-week Schrothkur: daily documentation of physical activities, number of steps (pedometer), general condition, consumption of medicines

Countries

Germany

Contacts

Public ContactDieter Frisch

Lehrstuhl für Public Health und Versorgungsforschung am IBE, Fachbereich Medizinische Klimatologie, Kurortmedizin und Prävention, LMU München

dfrisch@ibe.med.uni-muenchen.de+49 (0)89 2180-78214

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026